@article{article, title = {{Real-world evidence from a single U.K. cancer center for atezolizumab in second-line setting in advanced urothelial cancer: Moving beyond clinical trials.}}, publisher = {{American Society of Clinical Oncology (ASCO)}}, url = {{}}, year = {{2022}}, month = {{2}}, author = {{Hussain SA and Qureshi M and Tahir B and Rehan A and Catto JWF}}, doi = {{10.1200/jco.2022.40.6_suppl.461}}, volume = {{40}}, journal = {{Journal of Clinical Oncology}}, issue = {{6_suppl}}, pages = {{461-461}}, note = {{Accessed on 2025/05/29}}}